Table 1.
Drugs in completed and ongoing DCM-related clinical trials.
| Name | Target | Clinical phase | ClinicalTrials.gov ID | Status |
|---|---|---|---|---|
| AT001 | AKR1B1 | Phase 3 | NCT04083339 | Active, not recruiting |
| Ninerafaxstat | - | Phase 2 | NCT04826159 | Recruiting |
| Trimetazidine | ACAA2 | Phase 2 | NCT05556005 | Recruiting |
| Alpha-Lipoic Acid | - | N/A | NCT04141475 | Recruiting |
| Empagliflozin | SGLT2 | Phase 1 | ChiCTR2000038485 | Recruiting |
| Dapagliflozin | SGLT2 | N/A | NCT04591639 | Recruiting |
| Tadalafil | PDE5A | Phase 4 | NCT01803828 | Completed |
| Spironolactone | MR | N/A | ACTRN12609000789268 | Completed |
| Perhexiline maleate | CPT2, CPT1A | Phase 1/2 | NCT00628056 | Unknown |